Opioid dose and risk of road trauma in Canada: A population-based study

JAMA Internal Medicine

Volumn 173, Issue 3, 2013, Pages 196-201

  Gomes, Tara ^a,d,h   Redelmeier, Donald A ^a,b,e,f   Juurlink, David N ^a,b,e,f,g   Dhalla, Irfan A ^c,d,e,f   Camacho, Ximena ^a   Mamdani, Muhammad M ^a,c,d,e,f,h  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c Department of Medicine ^*  (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f Health Policy Management and Evaluation   (Canada)

^g Pediatrics   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL; HYDROMORPHONE; MORPHINE SULFATE; OPIATE; OXYCODONE;

ADULT; ARTICLE; CANADA; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; ANALGESICS, OPIOID; CANADA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 84874097113     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamainternmed.733     Document Type: Article

References (23)

1. Warner M, Chen LH, Makuc DM, Anderson RN, Minino AM. Drug poisoning deaths in the United States, 1980-2008. 2011. NHS Brief. http://www.cdc.gov/ nchs/data/databriefs/db81.htm. Accessed June 13, 2012.
2. Ramage-Morin PL. Motor vehicle accident deaths, 1979 to 2004. Statistics Canada. 2008. http://www.statcan.gc.ca/pub/82-003-x/2008003/article/5202433-eng. htm. Accessed June 13, 2012.
3. Centers for Disease Control and Prevention. Policy impact: Prescription painkiller overdoses. Updated December 19, 2011. http://www.cdc.gov/ homeandrecreationalsafety/rxbrief/index.html. Accessed June 13, 2012.
4. Centers for Disease Control and Prevention. Motor vehicle safety. Updated October 9, 2012. http://www.cdc.gov/motorvehiclesafety/. Accessed June 13, 2012.
5. Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/ paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain. 2006;22 (5):499-504.
6. Menefee LA, Frank ED, Crerand C, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5(1):42-49.
7. Ramaekers JG. Pitfalls in estimating drug-related crash risk. Trends Pharmacol Sci. 2003;24(3):114-115.
8. Mailis-Gagnon A, Lakha SF, Furlan A, Nicholson K, Yegneswaran B, Sabatowski R. Systematic review of the quality and generalizability of studies on the effects of opioids on driving and cognitive/psychomotor performance. Clin J Pain. 2012; 28(6):542-555.
9. Sjøgren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19(2):100-108.
10. Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol. 1995;3(4):432-466. http://paincenter .stanford.edu/iasp/Speakers/ Day%201%20Scott%20Strassels%20Syllabus/ effects%20of%20opioids%20on%20psychomotor.pdf. Accessed June 13, 2012.
11. Dubois S, Bédard M, Weaver B. The association between opioid analgesics and unsafe driving actions preceding fatal crashes. Accid Anal Prev. 2010;42(1): 30-37.
12. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Ann Epidemiol. 2007; 17(8):597-602.
13. Gibson JE, Hubbard RB, Smith CJ, Tata LJ, Britton JR, Fogarty AW. Use of selfcontrolled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol. 2009;169(6):761-768.
14. Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev. 2004;36(4):631-636.
15. Marquet P, Delpla PA, Kerguelen S, et al. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: A collaborative study. J Forensic Sci. 1998;43(4):806-811.
16. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol. 1992;136(7):873-883.
17. Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med. 2011;5(1):e13-e22. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3205807/. Accessed June 13, 2012.
18. Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society-American Academy of PainMedicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
19. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Updated April 30, 2010. http://nationalpaincentre.mcmaster.ca/opioid/. Accessed June 13, 2012.
20. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171(7):686-691.
21. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984;40(1):63-75.
22. Mamdani M, Sykora K, Li P, et al. Reader's guide to critical appraisal of cohort studies, 2: Assessing potential for confounding. BMJ. 2005;330(7497):960-962.
23. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: The TROUP study. Clin J Pain. 2010;26(1): 1-8.